Australia markets closed

Aurobindo Pharma Limited (AUROPHARMA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,466.35+8.55 (+0.59%)
At close: 03:29PM IST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/03/2024
31/03/2023
31/03/2022
31/03/2021
31/03/2020
Cash flows from operating activities
Net income
35,214,400
31,729,700
19,275,000
26,481,500
53,348,400
-
Depreciation & amortisation
-
14,919,100
12,445,800
11,265,200
10,553,900
-
Change in working capital
-
-16,750,700
-10,949,800
15,578,000
-10,666,500
-
Inventory
-
-13,036,800
-9,267,000
14,975,200
-16,217,400
-
Other working capital
-
-11,269,800
-3,336,500
23,118,400
14,552,400
-
Other non-cash items
-
-277,200
-299,600
122,800
-162,000
-
Net cash provided by operating activities
-
24,345,200
23,867,500
50,164,800
33,290,500
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-35,615,000
-27,204,000
-27,046,400
-18,738,100
-
Acquisitions, net
-
0
-1,969,700
-6,540,400
-4,278,400
-
Purchases of investments
-
-37,600
-20,141,000
-8,249,500
-3,137,800
-
Sales/maturities of investments
-
1,791,500
23,514,700
4,616,500
0
-
Other investing activities
-
-11,890,200
-16,608,400
749,300
-271,100
-
Net cash used for investing activities
-
-42,559,500
-39,777,500
-32,115,600
5,986,900
-
Net change in cash
-
-10,210,100
2,234,100
-11,643,500
25,628,000
-
Cash at beginning of period
-
43,922,700
41,625,100
53,299,100
27,468,200
-
Cash at end of period
-
33,854,300
43,922,700
41,625,100
53,299,100
-
Free cash flow
Operating cash flow
-
24,345,200
23,867,500
50,164,800
33,290,500
-
Capital expenditure
-
-35,615,000
-27,204,000
-27,046,400
-18,738,100
-
Free cash flow
-
-11,269,800
-3,336,500
23,118,400
14,552,400
-